Supply and Delivery of Drugs and Placebo for the CATIS-ICAS Research Study

The contract involves the supply and delivery of drugs and placebos for the CATIS-ICAS research study, managed by Hamilton Health Sciences under the Government of Canada. This solicitation, identified as HHS0674 [BF-104767], was posted on April 20, 2026, with a response deadline set for May 1, 2026. The nature of the contract is focused on a federal level, with an emphasis on providing pharmaceutical products essential for the successful execution of the research study. Key details include the requirement for the vendor to furnish both active drugs and placebos, which are critical for the controlled aspects of the study. Though no specific NAICS code or set-aside type was indicated, the contracting authority is available for inquiries, reflecting a structured and formal procurement process. The contract supports research endeavors through timely and precise delivery of medical supplies that contribute to advancing clinical investigations within the health sciences sector.